Adverse events · people with moderate to severe Crohn's disease in remission
Ustekinumab showed no clear difference in adverse events compared with placebo (high certainty).
1 finding from 1 review
Serious adverse events · people with moderate to severe Crohn's disease in remission
Ustekinumab showed no clear difference in serious adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with moderate to severe Crohn's disease in remission
Ustekinumab showed no clear difference in withdrawal due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Failure to maintain remission · people with moderate to severe Crohn's disease in remission
Briakinumab showed no clear difference in failure to maintain clinical remission compared with placebo (low certainty).
1 finding from 1 review
Failure to maintain clinical response · people with moderate to severe Crohn's disease in remission
Briakinumab showed no clear difference in failure to maintain clinical response compared with placebo (low certainty).
1 finding from 1 review
Resolution of symptoms · children with hypoglycaemia associated with moderate clinical symptoms of acute malaria or moderate respiratory tract infections
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Blood/plasma glucose concentrations at 20 minutes · children with hypoglycaemia associated with moderate clinical symptoms of acute malaria or moderate respiratory tract infections
1 finding from 1 review
Resolution of hypoglycaemia · children with hypoglycaemia associated with moderate clinical symptoms of acute malaria or moderate respiratory tract infections
It is very uncertain whether sublingual glucose changes resolution of hypoglycaemia Definition: (a) within 20 minutes (b)… compared with oral (swallowed) glucose (very low certainty).
1 finding from 1 review
Time to resolution of hypoglycaemia · children with hypoglycaemia associated with moderate clinical symptoms of acute malaria or moderate respiratory tract infections
1 finding from 1 review
Adverse events · children with hypoglycaemia associated with moderate clinical symptoms of acute malaria or moderate respiratory tract infections
1 finding from 1 review
Delay in treatment · children with hypoglycaemia associated with moderate clinical symptoms of acute malaria or moderate respiratory tract infections
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Improvement in acne severity assessed by a decrease in total inflammatory lesion count, measured in participants who were treated for a minimum period of 16 weeks (Changes from baseline in total inflammatory lesion count and number of participants... · participants with moderate and severe acne
1 finding from 1 review
Intervention not reported
Frequency of serious adverse effects 20 to 24 weeks · participants with moderate and severe acne
It is very uncertain whether the intervention changes frequency of serious adverse effects 20 to 24 weeks (very low certainty).
1 finding from 1 review
Intervention not reported
Improvement in acne severity assessed by physician's global evaluation 20 to 24 weeks · participants with moderate and severe acne
1 finding from 1 review
Change in apathy · Apathy in people with mild‐to‐moderate Alzheimer's disease
2 findings from 1 review
Change in apathy · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Adverse Events ‐ reported, but not analyzed in this review · Apathy in people with mild‐to‐moderate Alzheimer's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in NPS ‐ not investigated · Apathy in people with mild‐to‐moderate Alzheimer's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in cognition ‐ not investigated · Apathy in people with mild‐to‐moderate Alzheimer's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in functional performance · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review